Ionic Pharmaceutical Private Limited
About Ionic Pharmaceutical Private Limited
Data last updated:
Ionic Pharmaceutical Private Limited is a private limited company based in Ranaji Enclave Najafgarh, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC331390. Its GSTIN is 10AAECI8118C1Z6 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shankar Singh and Sarita Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot. No. – 81 C Kh No – 37/16/1 F/F M.S. Block, Ranaji Enclave Najafgarh, Delhi, India – 110043.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.65 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹67,470 (net margin 0.4%) and EBITDA of ₹2.04 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot. No. – 81 C Kh No – 37/16/1 F/F M.S. Block, Ranaji Enclave Najafgarh, Delhi, India – 110043
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ionic Pharmaceutical Private Limited
The main business activity of Ionic Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ionic Pharmaceutical Private Limited FY 2023 filings available
Ionic Pharmaceutical Private Limited reported revenue of ₹1.65 Cr (up 30% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Ionic Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 30% growth in the latest year. EBITDA rose 376% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ionic Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.04 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹67,470 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ionic Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ionic Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chaitali Tradelink Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | -63.0% | •••• | Kolkata, West Bengal, India |
| Nagnath Food Product Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 88.0% | •••• | Amreli, Gujarat, India |
| 3Phala Ayurcentre Private Limited | ₹1.65 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Chennai, Tamil Nadu, India |
| Biostem Pharma Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Shahabad Markanda, Haryana, India |
| Dry Land Farmers Producer Company Limited | ₹1.65 Cr (FY 2021) | •••• | •••• | 278.0% | •••• | Sankarankoil, Tamil Nadu, India |
| Ionic Pharmaceutical Private Limited this company | ₹1.65 Cr (FY 2023) | •••• | •••• | 30.0% | •••• | Ranaji Enclave Najafgarh, Delhi, India |
| Gloenfield Technologies Private Limited | ₹1.65 Cr (FY 2022) | •••• | •••• | 80.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Bheraghat Marbles Pvt Ltd | ₹1.65 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Rabhiaans Biotech Private Limited | ₹1.65 Cr (FY 2024) | •••• | •••• | 119.0% | •••• | Dehradur, Uttarakhand, India |
| Assetmax Interiors Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 309.0% | •••• | Delhi, India |
| Maarish Impex (OPC) Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | 227.0% | •••• | Tuticorin, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Ionic Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shankar Singh | Director | 22 Mar 2018 | 8 Years 6 Months | Current |
| Sarita Singh | Director | 22 Mar 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of Ionic Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ionic Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ionic Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sarita Singh was appointed as Director on 22 Mar 2018.
Credit Ratings, Litigation & Regulatory Alerts for Ionic Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ionic Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ionic Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECI8118C1Z6 | Bihar | Active | 12 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ionic Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ionic Pharmaceutical Private Limited
Ionic Pharmaceutical is an active private limited company based in Ranaji Enclave Najafgarh, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 March 2018 (8+ years old) and is registered under CIN U74999DL2018PTC331390.
Ionic Pharmaceutical reported revenue of ₹1.65 Cr for FY 2023 (up 30% YoY).
Ionic Pharmaceutical has 2 current directors:
- Shankar Singh - Director
- Sarita Singh - Director
Ionic Pharmaceutical reported a net profit of ₹67,470 (net margin 0.4%) and EBITDA of ₹2.04 Lakh (EBITDA margin 1.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ionic Pharmaceutical is 7% over three years. In the latest year (FY 2023) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ionic Pharmaceutical is 10AAECI8118C1Z6, registered in Bihar.
The CIN (Corporate Identification Number) of Ionic Pharmaceutical is U74999DL2018PTC331390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ionic Pharmaceutical was incorporated on 22 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ionic Pharmaceutical by revenue are Chaitali Tradelink Private Limited, Nagnath Food Product Private Limited, 3Phala Ayurcentre Private Limited, Biostem Pharma Private Limited, Dry Land Farmers Producer Company Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Sarita Singh was appointed as Director on 22 Mar 2018. Shankar Singh was appointed as Director on 22 Mar 2018.
The registered office of Ionic Pharmaceutical is at Plot. No. – 81 C Kh No – 37161 FF M.S. Block, Ranaji Enclave Najafgarh, Delhi, India – 110043.